PDGF-D signaling in portal myofibroblasts and hepatic stellate cells proves identical to PDGF-B via both PDGF receptor type α and β

Cellular Signalling

Volumn 27, Issue 7, 2015, Pages 1305-1314

  Borkham Kamphorst, Erawan ^a   Meurer, Steffen K ^a   Van de Leur, Eddy ^a   Haas, Ute ^a   Tihaa, Lidia ^a   Weiskirchen, Ralf ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Hepatic stellate cells; MMP; PDGF D; Portal myofibroblasts; TIMP 1

Indexed keywords

ADAPTOR PROTEIN; CRK2 PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR D; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; LYMPHOKINE; PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR BB; PROTEIN BINDING; SCDGFB PROTEIN, RAT; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE-1 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; CHIMERA; CONTROLLED STUDY; ENDOCYTOSIS; EXTRACELLULAR MATRIX; FIBROGENESIS; MALE; MYOFIBROSIS; NONHUMAN; PORTAL MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STELLATE CELL; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CYTOLOGY; DOWN REGULATION; DRUG EFFECTS; GENETICS; METABOLISM; MYOFIBROBLAST; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; CELLS, CULTURED; DOWN-REGULATION; ENDOCYTOSIS; HEPATIC STELLATE CELLS; LYMPHOKINES; MALE; MYOFIBROBLASTS; PLATELET-DERIVED GROWTH FACTOR; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-SIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UP-REGULATION;

EID: 84926294369     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2015.03.012     Document Type: Article

References (38)

1. Gressner A.M., Bachem M.G. Digestion 1995, 56:335-346.
2. Friedman S.L. J. Gastroenterol. 1997, 32:424-430.
3. Ramadori G., Saile B. Lab. Investig. 2004, 84:153-159.
4. Friedman S.L. J. Biol. Chem. 2000, 275:2247-2250.
5. LaRochelle W.J., Jeffers M., McDonald W.F., Chillakuru R.A., Giese N.A., Lokker N.A., et al. Nat. Cell Biol. 2001, 3:517-521.
6. Bergsten E., Uutela M., Li X., Pietras K., Ostman A., Heldin C.H., et al. Nat. Cell Biol. 2001, 3:512-516.
7. Borkham-Kamphorst E., van Roeyen C.R., Ostendorf T., Floege J., Gressner A.M., Weiskirchen R. J. Hepatol. 2007, 46:1064-1074.
8. Borkham-Kamphorst E., Kovalenko E., van Roeyen C.R., Gassler N., Bomble M., Ostendorf T., et al. Lab. Investig. 2008, 88:1090-1100.
9. Hudkins K.L., Gilbertson D.G., Carling M., Taneda S., Hughes S.D., Holdren M.S., et al. J. Am. Soc. Nephrol. 2004, 15:286-298.
10. Breitkopf K., van Roeyen C., Sawitza I., Wickert L., Floege J., Gressner A.M. Cytokine 2005, 31:349-357.
11. Wong L., Yamasaki G., Johnson R.J., Friedman S.L. J. Clin. Invest. 1994, 94:1563-1569.
12. Martin I.V., Borkham-Kamphorst E., Zok S., van Roeyen C.R., Eriksson U., Boor P., et al. Am. J. Pathol. 2013, 182:107-117.
13. Borkham-Kamphorst E., Alexi P., Tihaa L., Haas U., Weiskirchen R. Biochem. Biophys. Res. Commun. 2015, 457:307-313.
14. Borkham-Kamphorst E., Schaffrath C., Van de Leur E., Haas U., Tihaa L., Meurer S.K., et al. Biochim. Biophys. Acta 2014, 1843:902-914.
15. Meurer S.K., Tihaa L., Borkham-Kamphorst E., Weiskirchen R. Cell. Signal. 2011, 23:683-699.
16. Li Z., Dranoff J.A., Chan E.P., Uemura M., Sévigny J., Wells R.G. Hepatology 2007, 46:1246-1256.
17. Schäfer S., Zerbe O., Gressner A.M. Hepatology 1987, 7:680-687.
18. Fehrenbach H., Weiskirchen R., Kasper M., Gressner A.M. Hepatology 2001, 34:943-952.
19. Borkham-Kamphorst E., Stoll D., Gressner A.M., Weiskirchen R. Biochem. Biophys. Res. Commun. 2004, 317:451-462.
20. Borkham-Kamphorst E., Herrmann J., Stoll D., Treptau J., Gressner A.M., Weiskirchen R. Lab. Investig. 2004, 84:766-777.
21. Kazlauskas A., Cooper J.A. EMBO J. 1990, 9:3279-3286.
22. Friedman S.L., Arthur M.J. J. Clin. Invest. 1989, 84:1780-1785.
23. Czochra P., Klopcic B., Meyer E., Herkel J., Garcia-Lazaro J.F., Thieringer F., et al. J. Hepatol. 2006, 45:419-428.
24. Pinzani M., Gesualdo L., Sabbah G.M., Abboud H.E. J. Clin. Invest. 1989, 84:1786-1793.
25. Pinzani M., Milani S., Herbst H., DeFranco R., Grappone C., Gentilini A., et al. Am. J. Pathol. 1996, 148:785-800.
26. Li X., Pontén A., Aase K., Karlsson L., Abramsson A., Uutela M., et al. Nat. Cell Biol. 2000, 2:302-309.
27. Tallquist M., Kazlauskas A. Cytokine Growth Factor Rev. 2004, 15:205-213.
28. Yokote K., Hellman U., Ekman S., Saito Y., Rönnstrand L., Saito Y., et al. Oncogene 1998, 16:1229-1239.
29. Matsumoto T., Yokote K., Take A., Takemoto M., Asaumi S., Hashimoto Y., et al. Biochem. Biophys. Res. Commun. 2000, 270:28-33.
30. Eriksson A., Siegbahn A., Westermark B., Heldin C.H., Claesson-Welsh L. EMBO J. 1992, 11:543-550.
31. Claesson-Welsh L. J. Biol. Chem. 1994, 269:32023-32026.
32. Ikeda K., Wakahara T., Wang Y.Q., Kadoya H., Kawada N., Kaneda K. Hepatology 1999, 29:1760-1767.
33. Carloni V., Romanelli R.G., Pinzani M., Laffi G., Gentilini P. Gastroenterology 1997, 112:522-531.
34. Hayes B.J., Riehle K.J., Shimizu-Albergine M., Bauer R.L., Hudkins K.L., Johansson F., et al. PLoS One 2014, 9(3):e92925.
35. Thieringer F., Maass T., Czochra P., Klopcic B., Conrad I., Friebe D., et al. Gene 2008, 423:23-28.
36. Campbell J.S., Hughes S.D., Gilbertson D.G., Palmer T.E., Holdren M.S., Haran A.C., et al. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:3389-3394.
37. Burch M.L., Zheng W., Little P.J. Cell. Mol. Life Sci. 2011, 68:97-107.
38. Kamato D., Burch M.L., Piva T.J., Rezaei H.B., Rostam M.A., Xu S., et al. Cell. Signal. 2013, 25:2017-2024.